Header Logo

Fadi Chalhoub

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pacemaker, Artificial
4
2024
49
3.130
 Why?
Thromboembolism
3
2024
73
0.990
 Why?
Anticoagulants
4
2024
495
0.910
 Why?
Perioperative Care
2
2024
85
0.880
 Why?
Catheter Ablation
4
2022
154
0.850
 Why?
Syncope, Vasovagal
1
2023
8
0.830
 Why?
High-Frequency Jet Ventilation
1
2022
2
0.760
 Why?
High-Frequency Ventilation
1
2022
5
0.750
 Why?
Atrial Fibrillation
6
2024
837
0.750
 Why?
Defibrillators, Implantable
1
2024
265
0.720
 Why?
Patient Discharge
1
2022
511
0.600
 Why?
Cardiac Pacing, Artificial
3
2023
37
0.590
 Why?
Administration, Oral
2
2024
369
0.230
 Why?
Hematoma
1
2024
80
0.220
 Why?
Treatment Outcome
5
2022
5657
0.220
 Why?
Hypotension
1
2024
50
0.210
 Why?
Body Surface Potential Mapping
2
2013
4
0.200
 Why?
Equipment Design
2
2022
349
0.200
 Why?
Heart Conduction System
2
2013
54
0.200
 Why?
Equipment Failure
1
2022
67
0.190
 Why?
Tidal Volume
1
2022
41
0.190
 Why?
Humans
10
2024
63299
0.180
 Why?
Hypertension
2
2024
584
0.160
 Why?
Prospective Studies
3
2022
3285
0.150
 Why?
Pandemics
1
2022
673
0.140
 Why?
Thiophenes
1
2014
29
0.110
 Why?
Middle Aged
6
2024
17555
0.110
 Why?
Morpholines
1
2014
88
0.100
 Why?
Cardiac Catheters
1
2012
11
0.100
 Why?
Electrodes, Implanted
1
2012
37
0.100
 Why?
Heart Atria
1
2013
138
0.100
 Why?
beta-Alanine
1
2012
8
0.090
 Why?
Benzimidazoles
1
2012
54
0.090
 Why?
Registries
2
2014
888
0.090
 Why?
Image Enhancement
1
2012
192
0.090
 Why?
Aged
4
2022
14396
0.090
 Why?
Warfarin
1
2012
111
0.090
 Why?
Imaging, Three-Dimensional
1
2013
288
0.090
 Why?
Software
1
2013
389
0.080
 Why?
Algorithms
1
2013
1001
0.070
 Why?
Feasibility Studies
3
2014
568
0.060
 Why?
Angiotensinogen
1
2024
3
0.060
 Why?
Antihypertensive Agents
1
2024
166
0.050
 Why?
Double-Blind Method
1
2024
738
0.050
 Why?
Blood Pressure
1
2024
509
0.050
 Why?
RNA Interference
1
2024
618
0.040
 Why?
RNA
1
2024
423
0.040
 Why?
Sensitivity and Specificity
2
2013
1146
0.040
 Why?
Reproducibility of Results
2
2013
1649
0.040
 Why?
Male
5
2024
29823
0.040
 Why?
Follow-Up Studies
2
2014
2460
0.030
 Why?
Female
5
2024
32793
0.030
 Why?
Postoperative Complications
2
2014
1303
0.030
 Why?
Perioperative Period
1
2014
21
0.030
 Why?
Rivaroxaban
1
2014
19
0.030
 Why?
Factor Xa Inhibitors
1
2014
35
0.030
 Why?
Equipment Failure Analysis
1
2012
75
0.020
 Why?
Dabigatran
1
2012
20
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
860
0.020
 Why?
Swine
1
2012
374
0.020
 Why?
Anti-Arrhythmia Agents
1
2012
99
0.020
 Why?
Secondary Prevention
1
2012
163
0.020
 Why?
Hemorrhage
1
2012
267
0.020
 Why?
Sex Factors
1
2012
979
0.020
 Why?
Electrocardiography
1
2012
554
0.020
 Why?
Echocardiography
1
2012
501
0.020
 Why?
Incidence
1
2012
1375
0.020
 Why?
Age Factors
1
2012
1560
0.020
 Why?
Adult
1
2024
16784
0.020
 Why?
Retrospective Studies
1
2012
6631
0.010
 Why?
Animals
1
2012
20634
0.010
 Why?
Chalhoub's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_